Haematopoietic Stem Cell Transplant for Norovirus-Induced Intestinal Failure in X-linked Agammaglobulinemia

Since the first clinical description in 1952, immunoglobulin replacement therapy remains the mainstay of treatment of patients with X-linked agammaglobulinemia (XLA). However, this therapy only replaces IgG isotype and does not compensate for the loss of Bruton tyrosine kinase in non-B-lymphocytes....

Descripción completa

Detalles Bibliográficos
Autores principales: Shillitoe, Ben M. J., Ponsford, Mark, Slatter, Mary A., Evans, Jennifer, Struik, Siske, Cosgrove, Mike, Doull, Iolo, Jolles, Stephen, Gennery, Andrew R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221090/
https://www.ncbi.nlm.nih.gov/pubmed/34164761
http://dx.doi.org/10.1007/s10875-021-01088-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8221090/
https://www.ncbi.nlm.nih.gov/pubmed/34164761
http://dx.doi.org/10.1007/s10875-021-01088-2

Ejemplares similares